Calumet, Inc. EBITDA for the Trailing 12 Months (TTM) ending March 31, 2025: USD 79.50 M

Calumet, Inc. EBITDA is USD 79.50 M for the Trailing 12 Months (TTM) ending March 31, 2025, a -80.71% change year over year. EBITDA means earnings before interest, taxes, depreciation, and amortization, which measures a company's operating performance by excluding non-operating expenses.
  • Calumet, Inc. EBITDA for the Trailing 12 Months (TTM) ending March 31, 2024 was USD 412.10 M, a 90.00% change year over year.
  • Calumet, Inc. EBITDA for the Trailing 12 Months (TTM) ending March 31, 2023 was USD 216.90 M, a 285.94% change year over year.
  • Calumet, Inc. EBITDA for the Trailing 12 Months (TTM) ending March 31, 2022 was USD 56.20 M, a -224.34% change year over year.
  • Calumet, Inc. EBITDA for the Trailing 12 Months (TTM) ending March 31, 2021 was USD -45.20 M, a -123.99% change year over year.
Key Data
Date EBITDA Net Income EPS (Diluted) Shares (Diluted, Weighted)